Yifan Pharmaceutical's wholly-owned subsidiary, Suzhou Yifan Pharmaceutical, has won the bid for its Strong Cough Syrup in the National Chinese Patent Medicine Procurement Alliance's centralized procurement. The product is a national medical insurance catalog item. While current sales contribution is small, the win is expected to increase product accessibility and brand influence, though contract signing and market execution remain uncertain.
Summary generated by AI · Always verify with source document
Stock Code: 002019 Stock Abbreviation: Yifan Pharmaceutical Announcement Number: 2026-043
Yifan Pharmaceutical Co., Ltd. Announcement on the Winning of Centralized Procurement by a Wholly-Owned Subsidiary in the National Chinese Patent Medicine Procurement Alliance
The Company and all members of the Board of Directors guarantee the content of the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.